460
Views
0
CrossRef citations to date
0
Altmetric
Retraction

Statement of Retraction: Long-term systemic administration with low dose of 3,4-methylenedioxymethamphetamine causes photoreceptor cell damage in CD1 mice

This article refers to:
RETRACTED ARTICLE: Long-term systemic administration with low dose of 3,4-methylenedioxymethamphetamine causes photoreceptor cell damage in CD1 mice

We, the Editor and Publishers of Cutaneous and Ocular Toxicology have retracted the following article:

Xiu-Fang Lv, Li-Ming Tao & Hui Zhong (2019) Long-term systemic administration with low dose of 3,4-methylenedioxymethamphetamine causes photoreceptor cell damage in CD1 mice, Cutaneous and Ocular Toxicology, 38:1, 81-87, DOI: 10.1080/15569527.2018.1539007

An investigation was conducted and Figure 1d in the paper was found to be duplicated in another published article:

Haojiang Yang, Liming Tao, Lin Li. (2015) Long-Term Systemic Treatment With Methamphetamine Causes Retinal Damage in CD1 Mice. International Journal of Toxicology, 37: 6, 448-456, DOI: 10.1177/1091581818809356 (see Figure 1F)

When approached for an explanation, the authors did not provide their original data or any necessary supporting information. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. All authors listed in this publication have been informed.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.